Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,711 | -4,495 | -1,128 | -612 | -3,584 |
| Depreciation Amortization | 1 | 1 | 0 | 0 | 1 |
| Other Working Capital | -5,091 | -4,093 | -1,034 | -234 | 119 |
| Other Operating Activity | 1,510 | 837 | 41 | 20 | 140 |
| Operating Cash Flow | $-11,291 | $-7,751 | $-2,120 | $-826 | $-3,325 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | N/A | -2 | N/A | N/A |
| Other Investing Activity | 452 | -4 | 0 | 0 | 0 |
| Investing Cash Flow | $448 | $-4 | $-2 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 390 | 27 | N/A | N/A | N/A |
| Other Financing Activity | 47,947 | 47,947 | 5,450 | 3,675 | 1,163 |
| Financing Cash Flow | $48,338 | $47,974 | $5,450 | $3,675 | $1,163 |
| Beginning Cash Position | 1,638 | 1,638 | 1,638 | 1,638 | 3,799 |
| End Cash Position | 39,132 | 41,857 | 4,965 | 4,487 | 1,638 |
| Net Cash Flow | $37,495 | $40,220 | $3,328 | $2,849 | $-2,162 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,291 | -7,751 | -2,120 | -826 | -3,325 |
| Capital Expenditure | -4 | N/A | -2 | N/A | N/A |
| Free Cash Flow | -11,294 | -7,751 | -2,123 | -826 | -3,325 |